Company reported significant deterioration across multiple metrics: 23% revenue decline, $10 million net loss, $179 million noncash loss from Pro Farm foreclosure, nearly all $229 million debt classified as short-term due to acceleration notice, only $14 million cash on hand, ongoing litigation with noteholders, and operational challenges across most business segments. The combination of financial distress, legal uncertainty, and liquidity constraints presents substantial downside risk.
Also mentions BIOX
Articles that tag BIOX but are mainly about other companies.
None recently.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
